is retatrutide fda approved yet Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval: What 2025-2026

Common adverse reactions include gastrointestinal symptoms (which may lead to intestinal obstruction in severe cases), headache, migraine, dehydration, and erectile dysfunction

Copper Delivery Copper is an essential cofactor for enzymes such as lysyl oxidase (involved in collagen and elastin crosslinking) and superoxide dismutase (antioxidant defense)

However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor

Providers recommend GLP-1 receptor agonists for patients who cannot tolerate metformin, exceed a hemoglobin A1c (HbA1c) target by more than 1.5%, or fail to achieve glycemic goals within three months of treatment (20)